Sobi
The Executive Director, Payer & Corporate Accounts is a key leadership role within U.S. Market Access at Sobi, responsible for leading and integrating the Payer Accounts and Corporate Accounts teams. This position shapes access strategy for national and regional payers, integrated delivery networks, and hospital systems to ensure patient access to rare disease therapies. The role involves building organizational capabilities, establishing unified account strategies, and driving cross-functional execution across the Sobi portfolio.
Headquarters
Stockholm, Stockholm, Sweden
Company Size
1001-5000 employees
Founded
2009
Sobi is a specialised international biopharmaceutical company focused on transforming the lives of people with rare diseases by developing and delivering innovative medicines. The company invests heavily in R&D and maintains a strong pipeline, with expanded patient access and commercialization as core priorities. Headquartered in Stockholm, Sobi operates globally and partners with healthcare providers, patient communities and other stakeholders to bring novel therapies to market. It also emphasizes sustainability, transparency and investor engagement as part of its long‑term strategy.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sobi.
Director / Senior Director, Payer National Accounts (East)
Cristcot
Director, National Payer Accounts
Compass Pathways
Senior Director, Payer Accounts
Immatics
Senior Director, National Accounts
Sarepta Therapeutics
National Account Director, Payer Accounts
Zenas BioPharma
National Account Director, Payer Team
Ipsen